Featuring an interview with Prof Patrick Neven, including the following topics:
- Emergence of ESR1 mutations in ER-positive, HER2-negative breast cancer (0:00)
- Observed toxicity profile of oral selective estrogen receptor degraders (SERDs) (3:57)
- Emerging data with novel oral SERD combinations (6:31)
- Challenges for a general medical oncologist in breast cancer (8:41)
- Sequencing and selection of therapies in ER-positive, HER2-negative breast cancer (12:16)
- Evaluating the strategy of switching to an oral SERD during first-line endocrine therapy upon "molecular progression" (23:16)
Fler avsnitt av Research To Practice | Oncology Videos
Visa alla avsnitt av Research To Practice | Oncology VideosResearch To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
